http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5579400-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28a869d6fc950d50f6df03f549ca3afa |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate | 1978-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b4333993a74dbbd4defc2b4456b908c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95366632452db9fb2c831afa6dba21ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96271a972fc428d6e06d8fe413b500f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7ff4bbc942627e31a950d16f6ad2975 |
| publicationDate | 1980-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S5579400-A |
| titleOfInvention | Novel estradiol derivative, its preparation, and antitumor agent |
| abstract | NEW MATERIAL:3-Acyloxy-1,3,5( 10 )-estratriene-17β-( 5-fluoro-2,4-dioxo-pyrimidin-1-yl) acetate of formula I (R is acyl group of formulas IIWV, etc.). n USE: Anti-tumor agent, especially effective to the cancer of tissue or cells having estradiol-sensitivity. Carcinostatic agent for uterine cancer, mammary cancer, prostatic cancer, thyloidal cancer, etc. n PROCESS: The compound of formula I is prepared by substituting the 3-position OH group of 3-hydroxy-1, 3, 5 (10)-estratriene-17β-(5-fluoro-2, 4-dioxo-pyrimidin-1-yl) acetate with acyloxy group. n COPYRIGHT: (C)1980,JPO&Japio |
| priorityDate | 1978-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.